Triatomic Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-98,555
| Closed | -$316K | – | 10 |
|
|
2024
Q1 | $316K | Sell |
98,555
-10,000
| -9% | -$32.1K | 0.59% | 8 |
|
|
2023
Q4 | $532K | Buy |
108,555
+5,666
| +6% | +$27.8K | 0.68% | 14 |
|
|
2023
Q3 | $561K | Sell |
102,889
-18,277
| -15% | -$99.6K | 0.39% | 17 |
|
|
2023
Q2 | $813K | Buy |
121,166
+44,606
| +58% | +$299K | 0.83% | 12 |
|
|
2023
Q1 | $676K | Sell |
76,560
-54,245
| -41% | -$479K | 0.45% | 20 |
|
|
2022
Q4 | $999K | Sell |
130,805
-175,000
| -57% | -$1.34M | 0.84% | 7 |
|
|
2022
Q3 | $2.18M | Sell |
305,805
-24,176
| -7% | -$172K | 1.25% | 6 |
|
|
2022
Q2 | $2.67M | Buy |
329,981
+32,933
| +11% | +$266K | 2.45% | 6 |
|
|
2022
Q1 | $4.12M | Buy |
297,048
+228,108
| +331% | +$3.17M | 3.35% | 4 |
|
|
2021
Q4 | $1.93M | Buy |
+68,940
| New | +$1.93M | 1.19% | 15 |
|